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Abstract
Currently, our understanding of mechanisms underlying cell-mediated immunity and particularly of mechanisms that
promote robust T cell memory to respiratory viruses is incomplete. Interleukin (IL)-6 has recently re-emerged as an
important regulator of T cell proliferation and survival. Since IL-6 is abundant following infection with influenza virus, we
analyzed virus-specific T cell activity in both wild type and IL-6 deficient mice. Studies outlined herein highlight a novel role
for IL-6 in the development of T cell memory to influenza virus. Specifically, we find that CD4+ but not CD8+ T cell memory is
critically dependent upon IL-6. This effect of IL-6 includes its ability to suppress CD4+CD25+ regulatory T cells (Treg). We
demonstrate that influenza-induced IL-6 limits the activity of virus-specific Tregs, thereby facilitating the activity of virus-
specific memory CD4+ T cells. These experiments reveal a critical role for IL-6 in ensuring, within the timeframe of an acute
infection with a cytopathic virus, that antigen-specific Tregs have no opportunity to down-modulate the immune response,
thereby favoring pathogen clearance and survival of the host.
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Introduction
Infection with influenza virus is associated with significant
mortality particularly amongst children and the elderly. The
emergence of new strains, most notably avian virus H5N1, poses
an increasing pandemic threat underlining the need for further
studies into generation of anti-viral immunity. A consideration of
how cytokines modulate cellular immune responses will facilitate a
better understanding of the interplay between such pathogens and
the immune system and provide rationale for enhancing vaccine
efficacy. Interleukin (IL)-6, a multifunctional cytokine expressed by
both lymphoid and non-lymphoid cells (reviewed in [1]), has been
implicated in increasing the severity of disease in humans infected
with influenza virus, including H5N1. However, murine studies
indicate that IL-6 does not contribute significantly to the
pathogenesis of influenza virus, since the rate of morbidity and
mortality observed in mice infected with H5N1 are comparable in
both wild-type and IL-6 deficient mice [2,3]. IL-6 does however
play a pivotal role in regulating the immune system – the cytokine
plays a central role in resolving the innate immune response and
directing the transition from innate to acquired immunity – a
process that can, at least in part, be attributed to its effect on
recruitment, activation and survival of different leukocyte subsets
(reviewed in [4]). Although IL-6 is classically defined as a central
regulator of the acute phase response, it is increasingly evident that
IL-6 performs a pivotal role in influencing T cell responses. This
role of IL-6 appears to be crucial for the progression of
autoimmune conditions such as rheumatoid arthritis and Crohn’s
disease where IL-6 has been implicated in the retention of
activated T-cells within the affected tissue, a finding that might
provide a mechanistic basis for the highly therapeutic action of
blocking IL-6R antibodies in these diseases [5,6]. However IL-6
control of this process may represent only part of the story, since
IL-6 also plays a role in orchestrating T-cell polarization,
proliferation, survival, and effector function (reviewed in [4]).
Collectively, these studies point to a critical role for IL-6 in
directing antigen-specific T cell responses. To date however, the
influence of IL-6 on development of antigen-specific T cell
memory has not been explored. In this study we compared
influenza-specific CD4+ and CD8+ T cell memory after infection
of wild-type (WT) and IL-6 deficient (IL-62/2) C57BL/6 (B6)
mice with influenza virus. The results of this study were striking
and defined IL-6 as a selective regulator of long-term CD4+ T-cell
memory responses, through its capacity to limit the activity of
virus-specific Tregs.
Results
Influenza-specific CD4+ T cell responses but not CD8+ T
cell responses are impaired in IL-62/2 mice
We assessed whether IL-6 is produced following infection of
mice with influenza virus. Serum, removed from WT mice
infected intranasally 3 and 8 days earlier with 20 haemagglutina-
tion units (HAU) of influenza virus, was assessed by Cytometric
Bead Array. This method of analysis allowed us to compare serum
levels of IL-6, IL-10, MCP-1, IFNc, TNFa and IL-12 in the
infected mice. The results, shown in Figure 1, indicate a selective
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elevation in IL-6 secretion in the serum at these time-points. IL-6
levels returned to baseline levels following the establishment of the
memory phase of the infection (data not shown). Since IL-6
production was prominent during the acute phase of infection and
within the timeframe of virus specific T cell activation we
considered it reasonable to hypothesize that IL-6 plays a role in
shaping the T cell response to influenza virus.
Influenza-specific memory CD8+ T cell responses were
unimpaired in IL-62/2 mice
To define the role IL-6 performs in orchestrating the immune
response to viral infection, ex vivo studies tested whether IL-6 could
affect primary and memory T cell responses to influenza infection.
Firstly, CD8+ T cell activity was compared using cells derived from
WT and IL62/2 mice following influenza virus infection. MHC
class I tetramers comprising the Db-ASNENMDAM complex
were used to stain lymphocytes recovered during the primary
phase of the infection (day 10) and 8 weeks post-infection. The
data shown in Figure 2 indicates that no significant difference was
observed between the groups at day 10 post-infection whilst no
tetramer positive cells were observed in either group following ex
vivo staining of spleen cells 8 weeks post-infection (data not shown).
Functional activity of these cells was assessed by CTL assay
(Figure 3A and B) and again, no difference was observed in
influenza-specific cytotoxic activity measured in spleen cells
isolated from WT and IL-62/2 mice 2 and 8 weeks post-infection.
The presence of CD8+ T cells in the lungs of both WT and IL-62/
2 mice was also measured during days 2–12 of a primary
(Figure 3C) and secondary infection with influenza virus
(Figure 3D). A similar CD8+ T cell response was observed in the
lungs of WT and IL-62/2 mice during the primary infection and
following rechallenge with the same virus. Overall, these data
indicate that lack of IL-6 had no significant effect on the
generation or recall of the CD8+ T cell response to influenza virus.
Influenza-specific memory CD4+ T cell responses are
impaired in IL-62/2 mice
In light of the ability of IL-62/2 mice to generate a comparable
CD8+ T cell response to WT mice, influenza-specific CD4+ T cell
responses were also assessed in both groups of mice. Virus-specific
proliferation assays using 3H-thymidine incorporation were
performed on WT and IL62/2 splenic CD4+ T cells, isolated
either 2 weeks post infection (primary CD4+ T cell response), or at
8 weeks following a secondary infection (memory CD4+ T cell
response). At 2 weeks post infection no difference was observed in
influenza-specific CD4+ T cell proliferation between WT and
IL62/2 mice, with both groups exhibiting robust virus-specific
responses (Figure 4A). However, at 8 weeks post infection, the
difference between the two mouse strains was striking. Whilst
virus-specific proliferation was readily observed in WT mice, a
notable reduction in proliferation was observed in IL62/2 mice
(Figure 4B), indicating that influenza-specific memory CD4+ T cell
responses are severely impaired in the absence of IL-6. In further
support of this, we found that whilst TNFa-producing CD4+ T
cells could be observed following a 5 hour in vitro restimulation of
CD4+ T cells isolated from the spleens of WT mice infected 8
weeks previously with influenza virus, these cells were not observed
following restimulation of CD4+ T cells purified from IL-62/2
mice (Figure 4C). Collectively these data imply that the activity of
influenza-specific central memory T-cells (TCM cells, which retain
proliferative capacity after initial antigen challenge) and effector
memory T cells (TEM, which produce cytokines rapidly upon re-
Figure 1. IL-6 production post-infection with influenza virus.
WT mice were infected i.n. with 20 HAU H17 influenza virus. Three and
eight days after infection, serum levels of IL-6, IL-10, MCP-1/CCL2, IFN-c,
TNF-a, and IL-12 were measured in uninfected (A) and infected (B) mice
by Cytometric Bead Array.
doi:10.1371/journal.ppat.1000006.g001
Figure 2. Nucleoprotein (NP)-Tetramer-positive CD8+ T cells in
the spleens of influenza virus-infected mice. Representative dot
plots showing staining of spleen cells recovered from a WT and IL-62/
2 mouse 10 days post i.n. infection with 20 HAU H17 influenza virus.
The cells were stained with CD8-specific mAbs and either the NP-
Tetramer (Db-ASNENMDAM, NP-Tet) or an irrelevant tetramer compris-
ing Db and a peptide derived from Lymphocytic choriomeningitis virus
(Db-KAVYNFATC, GP-Tet). The plots are representative of 3 mice per
group.
doi:10.1371/journal.ppat.1000006.g002
Author Summary
Influenza virus poses a serious global health threat,
particularly in light of newly emerging strains such as the
avian virus H5N1. The generation of cell-mediated vaccines
against influenza virus requires an understanding of
mechanisms underlying effective virus-specific T cell
memory. This study explored the impact of a cytokine,
interleukin-6 (IL-6), on generation of effective influenza-
specific T cell memory. This cytokine was considered
important based on previous studies revealing its role in
promoting survival and activity of conventional T cells
whilst inhibiting the activity of T cells involved in
dampening down immunity (regulatory T cells). We found
that the activity of a subset of influenza-specific memory T
cells (CD4+ T cells) was diminished in the absence of IL-6
due to the inhibitory effects of regulatory T cells—an effect
that compromised protective anti-viral immunity. Since a
robust CD4+ T cell response is likely to be central to the
success of a vaccine against influenza virus, these findings
highlight the importance of IL-6 in promoting effective
cell-mediated immune responses, thereby facilitating
successful virus clearance.
IL-6 Influences Influenza-Specific T Cell Memory
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exposure to antigen) are both impaired in IL-62/2 mice. To
extend these observations, we assessed CD4+ T cell responses ex
vivo by measuring the presence of CD4+ T cells in the lungs of both
WT and IL-62/2 mice following the first and second exposure to
influenza virus. For this purpose, WT and IL62/2 mice were
initially infected (i.n) with influenza virus and then subsequently
re-infected by the same route 8 weeks later. CD4+ T cell numbers
in the lungs were then recorded during the first 2–12 days of the
first (Figure 4D) and second infection (Figure 4E). Although both
WT and IL-62/2 mice elicited primary responses to influenza
infection, the overall profile of CD4+ T cell infiltrating of the lung
indicates that the T cell response was slightly delayed in IL-62/2
mice consistent with previous reports (Figure 4D) [7]. These
differences were however more pronounced following the second
viral challenge (Figure 4E). In this respect, the number of CD4+ T
cells in the lungs was dramatically reduced in IL-62/2 mice as
compared to WT mice. Whilst a defect in trafficking may
contribute to this reduction in T cell number, the results are also
consistent with a profound failure of the influenza-specific CD4+ T
cell memory response detailed in Figures 4B and C above.
Re-challenge with homologous virus as described above poses
the problem that neutralizing antibodies, induced following the
primary infection may differ between WT and IL-62/2 mice
altering their ability to control the second infection thereby
impacting on the extent of the T cell response induced following
the second infection. Comparable neutralizing antibody activity
was observed in WT and IL-62/2 serum analyzed 8 weeks post
infection thus the impairment in the CD4+ T cell memory
response observed in the IL-62/2 mice did not impinge on their
ability to generate adequate neutralizing antibodies (Figure 5A).
Since the presence of neutralizing antibodies would confer
resistance to re-infection with a homologous virus resulting in
very little restimulation of memory T cells, a more stringent test of
T cell memory was performed. Mice infected 8 weeks previously
with the H17 strain of influenza were rechallenged with the
heterologous virus, PR8. This virus was considered appropriate
since serum from H17 infected mice failed to neutralize PR8 (data
not shown), but CD4+ T cells purified from the spleens of WT
H17-infected memory mice proliferated in vitro when co-cultured
with PR8-infected APCs indicating that the viruses share T cell
epitopes (Figure 5B). Four days post-infection with the PR8 virus,
CD4+ T cells in the lungs of both H17-memory and naı¨ve WT and
IL-62/2 mice were enumerated by flow cytometry. A pronounced
difference was observed in the number of CD4+ T cells in the
lungs of WT and IL62/2 H17 memory mice following rechallenge
with PR8 (Figure 6A). A significant increase in the number of
CD4+ T cells was detected in the lungs of WT H17-memory mice
4 days after PR8 infection compared to naı¨ve mice infected 4 days
previously with the PR8 virus. No such difference was observed in
the lungs of similarly infected IL-62/2 mice indicating an
impaired recall response in these animals. A comparison of virus
burden in both groups of animals revealed higher levels of virus in
the lungs of IL62/2 mice compared to the WT mice (Table 1).
This is likely to be due to the impaired CD4+ T cell responses since
no difference was observed in the CD8+ T cell response (measured
by enumerating tetramer-positive cells in lungs and spleen (data
not shown)) induced following rechallenge of both groups of mice
with PR8. To confirm that influenza-specific CD4+ T cells were
functionally impaired in H17-memory mice lacking IL-6, the
ability of the cells to proliferate in response to the H17 influenza
virus was compared by CFSE dilution (Figure 6B). Spleen cells
from both groups of mice were labeled with CFSE and stimulated
with APCs infected either with the H17 influenza virus or a
control recombinant vaccinia virus for 6 days. The percentage of
cells that had proliferated was assessed by CFSE dilution and their
capacity to produce IFNc was assessed by intracellular cytokine
staining. As indicated in Figure 6B, more influenza-specific
proliferation was observed in the cultures from WT mice than
IL-62/2 mice and a higher percentage of these cells produced
IFNc. Collectively, these data confirm that IL-6 plays an essential
role in the CD4+ T cell memory response to influenza virus. The
impact of IL-6 on the influenza-specific T cell response appears to
be selective for CD4+ T-cells implying that IL-6 has a different
effect on the behavior of CD4+ and CD8+ T cells. CD4+ and
CD8+ T-cells purified from naı¨ve WT mice express the
membrane-bound IL-6 receptor (IL-6R), whilst its expression is
downregulated on both populations upon activation ([8] and data
not shown). It is not possible therefore to attribute the effect of IL-
6 on CD4+ and CD8+ memory T cells to an obvious difference in
classical IL-6 signaling capacity.
Influenza-specific CD4+CD25+ regulatory T cells inhibit
the CD4+ T cell memory response in IL62/2 mice
Since IL-6 has been shown to abrogate suppression by Tregs [9]
and to suppress Treg development by TGFb [10], we postulated
that influenza-virus Treg activity would be more readily detectable
in IL-62/2 mice than WT mice and that these cells would
suppress the activity of virus-specific memory T cells. To test this
hypothesis, we first carried out proliferation assays using purified
CD4+ T cells depleted of CD25+ cells from both WT and IL-62/2
mice. In this respect, depletion of CD25+ cells had a variable affect
on proliferative responses observed in WT mice, removal of
CD25+ cells uncovered influenza-specific memory CD4+ T cell
responses in the majority of IL-62/2 mice (Figure 7A). This
experiment revealed that influenza-specific proliferative responses
can be detected in IL-62/2 mice and suggest that these responses,
and to a lesser extent, responses in WT mice, are subject to
suppression by Tregs. To more closely examine the responsiveness
of Tregs in IL-62/2 mice, we performed suppression assays
Figure 3. Influenza specific CD8+ T cell activity in WT and IL-62/
2mice. Peptide-specific CTL assays were carried out at 2 weeks (A) and
8 weeks (B) post i.n. infection with H17 influenza virus. B16 target cells
were pulsed with the NP68 peptide prior to use in a standard 5-h 51Cr
release assay. Total number of CD8+T cells recovered from lungs of WT
and IL-62/2 mice following primary (C) or secondary (D) i.n. challenge
with H17 influenza virus. Mice were analyzed individually, and values
shown are the mean6SD (n = 3 mice/group). The results are
representative of three independent experiments. Statistical signifi-
cance was evaluated using the Student’s t test.
doi:10.1371/journal.ppat.1000006.g003
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designed to compare 1) Treg activity following polyclonal
stimulation of the cells using CD3-specific mAbs (Figure 7B) and
2) influenza-specific Treg activity (Figures 7C and D) in both
groups of mice. Suppression assays were carried out using
CD4+CD25+ Tregs purified from WT and IL-62/2 mice infected
2 (Figure 7C) and 8 weeks (Figure 7D) previously with influenza
virus. CD4+CD25+ T cells derived from these mice were
incubated with CD4+CD252 T cells from a WT mouse infected
two weeks earlier with influenza virus. These T-cell cultures were
then stimulated in vitro with either influenza infected APCs or
uninfected APCs. Influenza-specific proliferation was measured by
[3H]-thymidine incorporation at day 5. As shown in Figures 7C
and D, CD4+CD25+ Tregs isolated from IL-62/2, but not WT
mice infected 8 weeks (7D) but not 2 weeks (7C) previously with
Figure 4. Influenza specific CD4+ T cell activity in WT and IL-62/2mice. Proliferation assays were carried out using CD4+ T cells purified from
spleens of WT and IL-62/2 mice 2 weeks (A) and 8 weeks (B) post i.n. infection with 20 HAU H17 influenza virus. Effectors were incubated with
irradiated WT splenocytes alone or WT splenocytes infected with inactivated H17 influenza or vaccinia virus. [3H]-Thymidine was added on day 5 and
proliferation measured by thymidine incorporation after 18 hrs. Mice were analyzed individually and values shown are the mean6SEM (n = 3 mice/
group). Spleen cells were isolated 8 weeks after primary H17 infection and influenza-specific CD4+ T cells were analyzed for intracellular TNF-a by flow
cytometry (C). Each symbol represents an individual mouse. Kinetic analysis of total CD4+ T cells infiltrated in lungs from WT and IL62/2 mice
following primary (D) and secondary (E) i.n. challenge with 20 HAU H17 influenza virus. Mice were analyzed individually and values shown are the
mean6SD (n = 3 mice/group). Statistical significance was evaluated using the Students t test.
doi:10.1371/journal.ppat.1000006.g004
Figure 5. Neutralizing activity in the serum of the H17
influenza virus memory mice. (A) Serum from WT and IL-62/2 mice
was harvested at 6–8 weeks post i.n. infection with 20 HAU of H17.
MDCK cells and serum samples were cultured in the presence of 10
HAU of H17 and the viability of the cells determined 3 days later using
the alamar blue assay. The presence of neutralizing antibodies in serum
was determined by comparing cell viability of MDCKs cultured with
serum from naı¨ve mice, with viability of MDCKs cultured with serum
from previously infected mice (see Materials and Methods for
calculation). Results are presented as the mean neutralization index
score6SEM at each dilution (n = 6–7 mice per group). (B) T cell cross-
reactivity of PR8 and H17 was measured in a CD4+ T cell proliferation
assay. Mice were infected i.n. with 20 HAU H17 virus and 8 weeks later
CD4+ T cells were purified and stimulated in vitro with PR8-infected
APCs. Proliferation was measured by [3H]-thymidine incorporation at
day 5. Each bar represents the mean value6SEM (n = 3 wells/group).
Statistical significance was evaluated using the Students t test.
doi:10.1371/journal.ppat.1000006.g005
Figure 6. Challenge of H17 influenza virus immune mice with
the heterologous virus, PR8. WT and IL-62/2 mice infected 6 weeks
previously with H17 influenza virus were rechallenged i.n. with 20 HAU
of the PR8 virus. Four days post secondary infection the lungs were
harvested and the number of CD4+ T cells analyzed by flow cytometry
(A). Proliferation and cytokine production was measured in splenocytes
of H17-immune mice re-challenged 4 days previously with PR8 virus (B).
The cells were labelled with CFSE and incubated for 6 days with H17
influenza-infected APCs as described in materials and methods. Specific
proliferation was measured CFSE dilution and IFNc production on gated
CD4+ cells. The dot plots show a representative of 5 mice per group.
doi:10.1371/journal.ppat.1000006.g006
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influenza virus, were able to suppress proliferation of WT
influenza-specific CD4+ T cells. This data is consistent with our
earlier observation that memory but not primary responses are
impaired in influenza-infected IL-62/2 mice and further supports
the view that IL-6 has an inhibitory effect on the activity of virus-
specific Tregs. We were unable to detect a greater increase in the
number of Tregs (by Foxp3 staining) in the lymph nodes or spleens
of influenza-infected IL-62/2 compared to WT mice. The
number of influenza-specific Treg may be very low thus detecting
an increase in cell number in the overall Treg population as a
result of the influenza virus infection might not be possible. No
significant difference was observed in the ability of WT and IL-62/
2 CD4+CD25+ Tregs to suppress CD4+CD252 T cell prolifera-
tion after stimulation with CD3-specific antibodies (Figure 7B)
indicating that there is no inherent failure of Tregs to perform
immunosuppressive functions in the IL-62/2 mice. Overall,
these data clearly indicate that influenza-specific CD4+ T cells,
from both WT and IL-62/2 mice, can be suppressed by Tregs,
and reveal a crucial role for IL-6 in inhibiting the activity of virus-
specific Tregs.
Discussion
In this study, we sought to address whether IL-6 plays a role in
shaping the T cell response to influenza virus. This was considered
a pertinent question since IL-6 has previously been shown to be an
important survival factor for naı¨ve T cells and to increase the
frequency of antigen-specific CD4+ T cells primed in vivo [8,11,12].
To address this question we compared virus-specific CD4+ T cell
responses in WT and IL-62/2 mice approximately three months
after infection with influenza virus. The results were striking.
Whilst no difference was observed in the influenza-specific CD8+
T cell responses, CD4+ T cell responses were minimal in the
absence of IL-6. The impairment in the CD4+ T cell responses was
observed only during the memory phase of the infection and not
the primary phase. Neutralising antibody responses were compa-
rable in WT and IL-62/2 mice though it is possible that over time,
this antibody response as well as the CD8+ T cell response may
wane more rapidly in the IL-62/2 mice as a result of the defect in
CD4+ T cell memory [13]. A previous publication by Kopf et al.
reported that IL-62/2 mice show a significant decrease in T-
helper dependent CTL responses but not in those thought to be T-
helper independent [14]. Similarly, the same study demonstrated
that CD4+ T cell dependent IgG antibody production but not T
cell-independent IgM responses were impaired in IL-62/2 mice
[14]. Thus, overall, it appears that IL-6 has a major effect on the
adaptive immune system primarily through its influence on the
activity of CD4+ T cells. The impact of the defect in CD4+ T cell
memory on clearance of influenza virus was assessed in our study.
When WT and IL-62/2 mice infected with the H17 strain of
influenza virus were subsequently rechallenged with the heterol-
ogous virus, PR8, we found a delay in virus clearance in IL-62/2
mice compared to WT mice. Since antibodies capable of
neutralizing the PR8 virus are not present in H17-memory mice,
any protection against re-infection is likely to be conferred by
cross-reactive T cells. Thus, it is likely that poorer control of virus
in the IL-62/2 mice is attributable to impaired CD4+ T cell
memory. Thus, whilst previous reports indicate no difference in
virus replication in WT and IL-62/2 mice infected for the first
time with influenza virus [2,3], protection against secondary
infection may well be compromised when IL-6 is absent.
Although IL-6 has been shown to act as a survival factor for
CD4+ T cells, we found no evidence of increased cell death
amongst lymphocytes infiltrating the lungs of IL-62/2 mice
compared to WT mice either after the primary or secondary
infection with influenza virus (data not shown). This observation
implies that a defect in T cell survival does not account for the
failure to detect an influenza-specific CD4+ T cell memory
response in the IL-62/2 mice. Recently, a series of reports have
highlighted that IL-6 inhibits the activity of Tregs [9,15]. We
therefore hypothesized that in the absence of IL-6 Tregs may
impinge upon the development of virus-specific memory T cells.
Indeed, whilst influenza-specific CD4+ T cell memory responses
were consistently low in IL-62/2 mice, we found that simply
depleting CD25+ cells (enriched for Tregs) from the population of
splenic CD4+ T cells was enough to allow measurement of
detectable anti-influenza virus responses in proliferation assays. An
increase in the influenza-specific proliferative response was
observed in a proportion of WT animals implying that Tregs do
develop, albeit to a lesser extent, following infection of WT mice.
To confirm that virus-specific Treg activity was more readily
detectable in the absence of IL6, we stimulated co-cultures of
CD4+CD252 cells (obtained from influenza-infected WT mice)
and CD4+CD25+ cells purified from either influenza-infected WT
or IL-62/2 mice with APCs infected with the virus. Suppression of
the influenza-specific response was observed only in cultures
containing CD4+CD25+ T cells purified from IL-62/2 mice and
not in cultures containing CD4+CD25+ T cells purified from WT
mice. These data indicate that IL-6 normally limits the suppressive
activity of Tregs either by restricting their expansion or their
suppressive capacity. Influenza virus activates DCs through
engagement with TLR 3, 7 and 8 [16,17] , resulting in production
of large amounts of IL-6 ([18] data not shown). Thus, influenza-
infected DCs may represent at least one relevant source of IL-6 in
the system under study here.
Our finding that IL-6 deficiency promotes the activity of
antigen-specific Tregs parallels observations made in a murine
model of asthma where blocking the mIL-6R with specific
antibodies led to an increase in the number and suppressor
activity of FoxP3 positive cells in the lungs of the experimental
mice [15]. This report indicated that IL-6 activated Tregs via the
mIL-6R whilst IL-6 responses in conventional effector T cells were
elicited via its soluble receptor (sIL-6R), a process known as IL-6
trans-signaling (reviewed in [19]). However due to lack of reagents
available to selectively manipulate IL-6 trans-signaling over the
course of the 8–10 week viral infection, it is difficult to gauge
whether a dual-mode of IL-6 signaling influences the outcome of
the anti-influenza response. Our findings do however support the
Table 1. Relative Virus Loads in WT and IL62/2 Mice.
Dilution of Lung
Homogenate
Infection of MDCK
Cells
Infection of MDCK
Cells
WT Lung IL62/2 Lung
1/3 + +
1/9 + +
1/27 2 +
1/81 2 +
1/243 2 +
Lung homogenates were prepared from mice (n = 4 per group) infected with
H17 and rechallenged with PR8 at day 4 post-secondary infection and three-
fold dilutions were incubated with MDCK cells. After 3 days cell viability was
assessed using the Alamar Blue assay. + denotes dilutions of lung homogenate
resulting in infection of MDCK cells. 2 denotes dilutions of lung homogenate
where no infection of MDCK cells was observed.
doi:10.1371/journal.ppat.1000006.t001
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premise that the major target of IL-6 activity in our influenza
model is the Treg population rather than conventional CD4+ T
cells. Whilst the CD4+ memory T cell response is diminished in IL-
62/2 mice, due to the suppressive effect of Tregs, the memory
CD8+ T cell response is unimpaired. This observation implies that
CD4+ and CD8+ T cells differ in their susceptibility to suppression
by Tregs. It is not clear why this should be the case since CD8+ T
cells can be suppressed by Tregs under some circumstances [20].
Ultimately, a better understanding of how Tregs exert their
suppressive effects in vivo will help clarify this issue.
Development of virus-specific Tregs in the absence of IL-6 may
be explained by the recently described role of IL-6 in steering the
commitment of naı¨ve CD4+ T cells. Bettelli et al. demonstrated
that IL-6 suppresses development of Tregs induced by TGFb [10],
a cytokine shown to facilitate differentiation and expansion of
Tregs [21,22]. With this in mind, it is possible that TGFb is also
produced during the immune response to influenza virus, which in
the absence of IL-6 promotes expansion of Tregs. Bettelli et al. also
showed that a combination of IL-6 and TGFb directs the
commitment of naı¨ve T-cells towards an IL-17-secreting CD4+
T-helper (Th-17) population [10]. We saw no evidence of IL-17-
secreting CD4+ T (Th-17) cells in the primary or secondary
response to the influenza infection ruling out an essential role for
these in development of virus-specific CD4+ T cell memory in WT
mice.
Collectively, the data presented in this study point to a critical
role for IL-6 in promoting memory CD4+ T cell responses. This
may be due in part to the activities of IL-6 in promoting survival,
proliferation and migration of antigen-specific T cells but as
described in this study, a major pathway through which IL-6
promotes CD4+ T cell memory is through its inhibitory effect on
virus-specific Tregs. The involvement of Tregs in infectious disease
is curious. Many groups have studied Tregs in chronic infection
and have, in some cases, attributed their involvement to a need for
limiting pathogen-induced immunopathology [23,24]). In the case
of acute infection, the question that arises is why should Tregs be
involved at all? Results of a recent study investigating the turnover
of human Tregs imply that Tregs can arise from the antigen-
specific memory T cell pool and are relatively short-lived
compared to other T cells [25]. These findings led the authors
to propose that antigen-specific Tregs facilitate resolution of an
immune response without compromising the ability of the immune
system to respond to a second challenge with the same antigen.
These data imply that Tregs limit a primary T cell response
without necessarily impinging on a memory response. Our
findings imply that an absence of IL-6 favors conditions that
enhance survival of Tregs allowing them to persist and inhibit the
memory T cell response. The precise nature of these conditions
remains to be defined. However it is conceivable that the cytokine
milieu induced in response to antigenic challenge in the absence
of IL-6 may influence the outcome of the response. In
consideration of the question ‘‘why should Tregs play a role in
acute infections?’’ - we would suggest that production of IL-6 by
virus-infected cells serves two purposes – to promote priming of
antigen-specific effector T cells, and to inhibit priming of antigen-
specific Tregs thereby ensuring, within the time-frame of an acute
infection, that antigen-specific Tregs have in fact, no opportunity
to play a role.
Figure 7. Influenza-specific suppressor activity in WT and IL-62/2 mice. Mice were infected i.n. with 20 HAU of influenza virus (H17). Eight
weeks after infection, splenocytes from WT and IL62/2mice were harvested. (A) Purified CD4+ T cells were tested for proliferation against inactivated
H17 before (ND) or after (D) depletion of CD25+ T cells. Influenza-specific proliferation in both populations was measured by [3H]-thymidine
incorporation at day 5. Each symbol represents an individual mouse and the lines join responses in undepleted (ND) and CD25-depleted (D) CD4+ T
cell populations. A stimulation index greater than 2 was considered a positive response. (B) CD4+CD25+ cells from WT and IL-62/2 mice, infected 2 or
8 weeks previously, were isolated from splenocytes and their suppressive capacity was evaluated by incubation at a ratio of 1:1 with CD4+ T cells from
a WT mouse infected 2 weeks previously with H17 influenza virus. The cells were stimulated with either APCs exposed to 1 mg/ml anti-CD3 mAbs (B)
or influenza infected APCs (C and D). Proliferation was measured by [3H]-thymidine incorporation at day 5. CD4+CD25+ cells from 4 individual WT and
IL-62/2mice were analyzed and each bar represents the mean value6SEM of each group. Statistical significance was evaluated using the Students t
test.
doi:10.1371/journal.ppat.1000006.g007
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Although the concerted activity of many arms of the immune
system contribute to pathogen clearance, CD4+ T cells play a
central role both in promoting and coordinating these activities
and in facilitating long-term CD8+ T cell memory and B cell
memory. Induction of a robust CD4+ T cell response is therefore
likely to be critical to the success of any vaccine strategy. The
results of this study imply that co-administration of IL-6 with an
anti-influenza virus vaccine will promote development of protec-
tive immunity through optimal induction of a virus-specific
memory CD4+ T cell response.
Materials and Methods
Influenza virus
Recombinant Influenza A virus strain E61-13-H17 (H17,
H3N2) and Influenza A virus strain A-PR8-34 (PR8, H1N1),
were obtained from the National Institute for Medical Research
(London, UK) [26], Both H17 and PR8 were amplified in
embryonated chicken eggs as described previously and haemag-
glutination assays conducted to determine the viral titre [27].
Infection of mice with Influenza virus
Experiments were conducted on 6–8 week old, female, C57/
BL/6 wild-type (WT) and IL-6 deficient (IL-62/2) mice, bred in-
house at Cardiff University. Mice were housed in individually
ventilated cages and allowed access to standard mouse chow and
water ad libitum. Mice were infected intra-nasally (i.n.) with either
20 HAU of H17 or PR8 in 20 ml of sterile PBS, as indicated in
individual experiments. All experimental procedures conducted
were in compliance with the UK Home Office.
Analysis of serum cytokines
The presence of IL-6, IL-10, MCP-1, IFNc, TNFa, and IL-12
was assessed in serum derived from naı¨ve, uninfected mice or from
mice 3 and 8 days post infection with H17. An Inflammatory
Cytometric Bead Array Kit (BD Biosciences, USA) was used
according to the manufacturers’ guidelines and the presence of
each cytokine was analysed by flow cytometry (FACS-CALI-
BURH; Becton Dickinson, CA, USA).
Cytotoxic lymphocyte (CTL) assay
46106 splenocytes derived from WT and IL62/2 mice at either 2
or 8 weeks post-primary infection with H17 were stimulated with
16106 irradiated APCs loaded with 100 ml NP68 peptide (1026 M)
and incubated at 37uC. After 2 days in culture, IL-2 (10 units/ml)
was added and the cells cultured for an additional 3 days. Cultures
were then diluted 1:3 and incubated for 4–5 hours in the presence of
51Cr-labelled, NP68 peptide- or irrelevant peptide-loaded B16 cells
(16104 cells/well) at 37uC. To generate maximal lysis, 5% Triton
6100 was added to the cultures, whilst culture media alone was
added as an indication of minimal lysis. Gamma emission was
measured as a readout of 51Cr-release from the cells. Influenza
specific CTL activity was measured as described previously.
Flow cytometry and FACS analysis
Anti-CD4-FITC and anti-CD4-alexa fluor 647 were purchased
from Caltag Laboratories (Burlingame, CA, USA). Anti-CD8-
PerCP-Cy5.5, anti-CD4-PerCP-Cy5.5, anti-IL-6Receptor-PE, an-
ti-IFNc-APC, anti-CD25-FITC, anti-TNFa-alexa fluor 488, anti-
CD16/CD32-Fc Block, streptavidin-PerCP-Cy5.5 were purchased
from BD Pharmingen (San Diego, CA, USA). Anti-IL-6Receptor-
purified was purchased from Biolegend (San Diego, CA, USA).
Chicken-anti-rat-alexa fluor 647 was purchased from Invitrogen
Molecular Probes (Paisley, UK). Anti-IL-6Receptor-biotinylated
was purchased from R & D Systems (Minneapolis, USA). The PE-
labelled NP tetramer (Db-ASNENMDAM [28]) and control GP
tetramer (Db-KAVYNFATC) used in this study was generated in-
house using previously described methods [29]. Cells stained with
directly conjugated antibodies were incubated with 1–2 mg/ml of
antibody for 30 minutes at 4uC prior to washing and resuspending
in FACS buffer (PBS, 2% FCS, 2 mM EDTA). Unconjugated and
biotinylated antibodies required secondary staining with 1 mg/ml
of chicken anti-rat alexa fluor 647 and streptavidin-PerCP-Cy5.5
respectively, prior to washing and resuspension in FACS buffer.
Cells were fixed with FACS Fix buffer (PBS, 2% FCS, 2 mM
EDTA, 2% Formalin) prior to analysis.
In all cases the cells were analysed by flow cytometry (FACS-
CALIBURH; Becton Dickinson, CA, USA) and the data analysed
using FlowJo Software (Ashland, OR, USA).
Intracellular TNFa staining
Single cell suspensions were prepared from spleens of mice 8
weeks after primary H17 infection. Cells were incubated at 37uC
for 5 hours in the presence of CD28 (1 mg/ml), BrefeldinA (1 mg/
ml) and 10 HAU of H17 or 104 PFU of recombinant vaccinia virus
as an irrelevant virus control. Following incubation the cells were
washed with FACS buffer and stained for intracellular TNFa using
a Cytofix/Cytoperm Kit (BD Pharmingen, San Diego, CA, USA)
according to the manufacturers instructions, prior to resuspension
in FACS buffer and 100000 lymphocytes were acquired on a
FACSCalibur flow cytometer. Total numbers of TNFa+ CD4+ T
cells were calculated based on percentage of TNFa+ cells analyzed
by flow cytometry.
CFSE labelling and intracellular IFNc staining
A single cell-suspension of splenocytes was prepared from the
spleens of mice at day 4 post-rechallenge with PR8 virus.
Splenocytes were labelled with 0.5 mM CFSE (Molecular Probes)
and 56105cells/well were stimulated with 10 HAU of H17 and
CD28 (1 mg/ml). Cells were incubated for 6 days at 37uC. For
intracellular IFN-c detection, influenza pulsed dendritic cells (DCs)
were generated from splenic DCs derived from naı¨ve WT mice,
isolated by low density gradient centrifugation as previously
described [30] and incubated overnight with 400 HAU of H17.
Following 6 days incubation proliferating cells were washed with
culture media (RPMI+10% FCS) and incubated in the presence of
CD28 (1 mg/ml), BrefeldinA (1 mg/ml) and influenza-pulsed DCs
for 5 hours at 37uC. Intracellular staining for the presence of IFNc
was performed as outlined previously.
Determination of H17 neutralizing antibody titres
Serum from both WT and IL-62/2 mice was removed at 6–8
weeks post primary infection with H17 and from uninfected, naı¨ve
WT mice. MDCK cells at 50% confluence were plated into flat-
bottomed 96 well plates and cultured in the presence of 10 HAU
of H17 and serum at a starting concentration of 1:10 and three-
fold dilutions thereafter. The cells were cultured for 3 days at 37uC
prior to the assessment of cell viability using alamar blue
(Biosource International, Carmillo, CA, USA). The viability of
the cells was calculated according to the manufacturers’ guidelines.
Data is expressed as the antibody concentration at which the
infectivity of 10 HAU of H17 virus was inhibited by 50%.
Determination of relative virus load
Lungs from mice infected with H17 and rechallenged with PR8
were extracted at day 4 post-secondary infection and homogenised
in 1ml of serum free media. MDCK cells at 50% confluence were
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plated into flat-bottomed 96 well plates and cultured with three-
fold dilutions of lung homogenate. The cells were cultured for 3
days at 37uC prior to the assessment of cell viability using alamar
blue (Biosource international, Carmillo, CA, USA). The viability
of the MDCK cells cultured with a standard PR8 virus
preparation (positive control), no virus (negative control) and
different dilutions of lung homogenate was assessed.
Influenza virus-specific CD4+ T cell proliferation
Splenic CD4+ T cells derived from WT and IL-62/2 mice at 6–
8 weeks post-primary H17 infection were purified by positive
MACS microbead selection (Miltenyi Biotec, Bergisch-Gladbach,
Germany) according to the manufacturers’ instructions. Spleno-
cytes derived from a naı¨ve, WT mouse were used as a source of
APCs and were infected with 100 HAU of inactivated H17 for 1–
2 hours at 37uC prior to irradiation at 2400cGy. Non-influenza
infected, irradiated splenocytes were used as a negative control.
16105 CD4+ ‘effector’ cells were cultured in the presence of
66105 APCs in 96 well round bottom plates. Cells were incubated
for 6 days at 37uC, with [3H]-thymindine added for the final
18 hours of the study. Cell proliferation was assessed by [3H]-
thymidine incorporation.
Suppression assays
CD4+ CD25+ T cells were purified from splenocytes, derived
from WT and IL-62/2 mice at 8 weeks post-primary H17
infection, using a CD4+ CD25+ Regulatory T Cell Isolation Kit
(Miltenyi Biotec, Bergisch Gladbach, Germany) according to the
manufacturer’s instructions. 16105 CD4+ ‘effector’ cells from a
WT mouse at 2 weeks post-primary H17 infection, were isolated as
described previously, and incubated with the CD4+ CD25+ T cells
at a ratio of 1:1 in 96 well plates. The CD4+ ‘effector’ cells were
stimulated to proliferate by the addition of either 66105 irradiated
splenic APCs, infected with 100 HAU of inactivated H17 or
treated with 1 mg/ml of anti-CD3 mAb to the cells. Cells were
incubated for 6 days at 37uC, with [3H]-thymindine added for the
final 18 hours of the study. Cell proliferation was assessed by [3H]-
thymidine incorporation.
Statistical testing
All statistical differences determined in this study used the
paired means Students T test. P values of #0.05 were considered
significant (*), with values of #0.01 considered highly significant
(**).
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